Pesquisas alternativas:
complexes traits » complex traits (Expandir a Pesquisa), complexes targets (Expandir a Pesquisa), complexes its (Expandir a Pesquisa)
cooper jason » cooper john (Expandir a Pesquisa), cooper alan (Expandir a Pesquisa), cooper james (Expandir a Pesquisa)
2 complexes » 2 complex (Expandir a Pesquisa)
nano carlos » cano carlos (Expandir a Pesquisa), nino carlos (Expandir a Pesquisa), nuno carlos (Expandir a Pesquisa)
traits non » trains non (Expandir a Pesquisa), traits can (Expandir a Pesquisa), traits new (Expandir a Pesquisa)
nacl nano » nacl kno (Expandir a Pesquisa), nacl nabr (Expandir a Pesquisa)
j cooper » i cooper (Expandir a Pesquisa)
7.5 nacl » 3.5 nacl (Expandir a Pesquisa), 0.9 nacl (Expandir a Pesquisa)
complexes traits » complex traits (Expandir a Pesquisa), complexes targets (Expandir a Pesquisa), complexes its (Expandir a Pesquisa)
cooper jason » cooper john (Expandir a Pesquisa), cooper alan (Expandir a Pesquisa), cooper james (Expandir a Pesquisa)
2 complexes » 2 complex (Expandir a Pesquisa)
nano carlos » cano carlos (Expandir a Pesquisa), nino carlos (Expandir a Pesquisa), nuno carlos (Expandir a Pesquisa)
traits non » trains non (Expandir a Pesquisa), traits can (Expandir a Pesquisa), traits new (Expandir a Pesquisa)
nacl nano » nacl kno (Expandir a Pesquisa), nacl nabr (Expandir a Pesquisa)
j cooper » i cooper (Expandir a Pesquisa)
7.5 nacl » 3.5 nacl (Expandir a Pesquisa), 0.9 nacl (Expandir a Pesquisa)
1
Por Grew, David J., Cooper, Benjamin T., Nguy, Susanna, Halperin, Jason, Sanfilippo, Nicholas J.
Publicado no Front Oncol (2014)
“... with no acute Grade 4 or 5 toxicities. Fifteen patients (63%) were alive and disease-free. Two- and 5-year OS...”Publicado no Front Oncol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Roiser, Jonathan P., Cook, Lynnette J., Cooper, Jason D., Rubinsztein, David C., Sahakian, Barbara J.
Publicado em 2005
Obter o texto integralPublicado em 2005
Obter o texto integral
Obter o texto integral
Artigo
3
4
Por Liadi, Ivan, Roszik, Jason, Romain, Gabrielle, Cooper, Laurence J.N., Varadarajan, Navin
Publicado em 2013
“... advantages to using CAR(+) T cells for the treatment of cancers including the ability to target non-MHC...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“...With some of the richest economies in the world, the Gulf Cooperation Council (GCC) is undergoing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
7
Por Dobrow, Mark J, Cooper, Mary Anne, Gayman, Karen, Pennington, Jason, Matthews, Joanne, Rabeneck, Linda
Publicado em 2007
“... College Health Sciences Centre was deamalgamated into two separate hospitals: Women’s College Hospital...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Artigo
8
Por Mathias, Jason Scott, Agrawal, Ankit, Feinglass, Joe, Cooper, Andrew J, Baker, David William, Choudhary, Alok
Publicado em 2013
“... and clinically actionable 5 year life expectancy index. MATERIALS AND METHODS: We developed the index using EHR...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Panizza, Benedict J., de Souza, Paul, Cooper, Adam, Roohullah, Aflah, Karapetis, Christos S., Lickliter, Jason D.
Publicado no EBioMedicine (2019)
“... tiglate in patients with solid tumors. METHODS: Tigilanol tiglate was administered in a multicentre, non...”Publicado no EBioMedicine (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“.... elegans models of PD have been generated including transgenic worms that express α-synuclein or LRRK2...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Sulkowski, Jason P., Cooper, Jennifer N., Lopez, Joseph J., Jadcherla, Yamini, Cuenot, Alissabeth, Mattei, Peter, Deans, Katherine J., Minneci, Peter C.
Publicado em 2014
“...%) being the most prevalent. Within two years of discharge, 54.7% were readmitted, 5.2% had a repeat TEF...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Sulkowski, Jason P., Preston, Thomas J., Cooper, Jennifer N., Duffy, Victoria L., Deans, Katherine J., Chicoine, Louis G., Minneci, Peter C.
Publicado no J Extra Corpor Technol (2014)
“... with an average weight of 3.4 kg (standard deviation .7) had a total of 27 separate ECMO runs during the study...”Publicado no J Extra Corpor Technol (2014)
Obter o texto integral
Obter o texto integral
Artigo
13
14
Por Dua, Anahita, McMaster, Jason, Desai, Pathik J., Desai, Sapan S., Kuy, SreyRam, Mata, Maggy, Cooper, Jamie
Publicado em 2014
“...) were admitted to hospital with 66% (58) of them discharged within 48 hours. Two (2%) patients had an ER...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Cooper, Jason P., Farah, Rafic J., Stevenson, Philip A., Gooley, Ted A., Storb, Rainer, Scott, Bart L.
Publicado no Biol Blood Marrow Transplant (2019)
“... conditioning. Donor sources included HLA-matched related (38.2%), HLA-matched unrelated (34.5%), single HLA...”Publicado no Biol Blood Marrow Transplant (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Sulkowski, Jason P., Cooper, Jennifer N., Pearson, Erik G., Connelly, James T., Rintoul, Natalie, Kilbaugh, Todd J., Deans, Katherine J., Minneci, Peter C.
Publicado no J Extra Corpor Technol (2014)
“... (interquartile range, 2.8–14.0 kg) and median ECMO run of 12 days (interquartile range, 5–19 day). There was a...”Publicado no J Extra Corpor Technol (2014)
Obter o texto integral
Obter o texto integral
Artigo
17
Por Driedger, S Michelle, Kothari, Anita, Graham, Ian D, Cooper, Elizabeth, Crighton, Eric J, Zahab, Melanie, Morrison, Jason, Sawada, Michael
Publicado em 2010
“... mapping innovation as a KT strategy within the non-profit (public) health sector, reflecting...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Cooper, Jason F, Dues, Dylan J, Spielbauer, Katie K, Machiela, Emily, Senchuk, Megan M, Van Raamsdonk, Jeremy M
Publicado no NPJ Parkinsons Dis (2015)
“... crossed transgenic worm models of PD expressing either human mutant α-synuclein (A53T) or LRRK2 (G2019...”Publicado no NPJ Parkinsons Dis (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Cooper, Jason F., Machiela, Emily, Dues, Dylan J., Spielbauer, Katie K., Senchuk, Megan M., Van Raamsdonk, Jeremy M.
Publicado no Sci Rep (2017)
Obter o texto integralPublicado no Sci Rep (2017)
Obter o texto integral
Obter o texto integral
Artigo
20
Por Han, Sung Yeon Sarah, Cooper, Jason D., Ozcan, Sureyya, Rustogi, Nitin, Penninx, Brenda W.J.H., Bahn, Sabine
Publicado no Transl Psychiatry (2019)
“...), 37 subthreshold individuals who developed MDD within two or four years (extrapolation test set...”Publicado no Transl Psychiatry (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo